PAXI_HUMAN - dbPTM
PAXI_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PAXI_HUMAN
UniProt AC P49023
Protein Name Paxillin
Gene Name PXN
Organism Homo sapiens (Human).
Sequence Length 591
Subcellular Localization Cytoplasm, cytoskeleton . Cell junction, focal adhesion . Cytoplasm, cell cortex . Colocalizes with integrins at the cell periphery. Colocalize with PXN to membrane ruffles and the leading edge of migrating cells (PubMed:23128389).
Protein Description Cytoskeletal protein involved in actin-membrane attachment at sites of cell adhesion to the extracellular matrix (focal adhesion)..
Protein Sequence MDDLDALLADLESTTSHISKRPVFLSEETPYSYPTGNHTYQEIAVPPPVPPPPSSEALNGTILDPLDQWQPSSSRFIHQQPQSSSPVYGSSAKTSSVSNPQDSVGSPCSRVGEEEHVYSFPNKQKSAEPSPTVMSTSLGSNLSELDRLLLELNAVQHNPPGFPADEANSSPPLPGALSPLYGVPETNSPLGGKAGPLTKEKPKRNGGRGLEDVRPSVESLLDELESSVPSPVPAITVNQGEMSSPQRVTSTQQQTRISASSATRELDELMASLSDFKIQGLEQRADGERCWAAGWPRDGGRSSPGGQDEGGFMAQGKTGSSSPPGGPPKPGSQLDSMLGSLQSDLNKLGVATVAKGVCGACKKPIAGQVVTAMGKTWHPEHFVCTHCQEEIGSRNFFERDGQPYCEKDYHNLFSPRCYYCNGPILDKVVTALDRTWHPEHFFCAQCGAFFGPEGFHEKDGKAYCRKDYFDMFAPKCGGCARAILENYISALNTLWHPECFVCRECFTPFVNGSFFEHDGQPYCEVHYHERRGSLCSGCQKPITGRCITAMAKKFHPEHFVCAFCLKQLNKGTFKEQNDKPYCQNCFLKLFC
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MDDLDALL
-------CCHHHHHH
9.0319413330
2 (in isoform 4)Acetylation-66.2422814378
2 (in isoform 4)Phosphorylation-66.2425159151
3 (in isoform 4)Phosphorylation-45.1925159151
4 (in isoform 4)Phosphorylation-3.4629507054
19PhosphorylationESTTSHISKRPVFLS
HHHCCCHHCCCEECC
19.72-
26PhosphorylationSKRPVFLSEETPYSY
HCCCEECCCCCCCCC
23.1726356563
29PhosphorylationPVFLSEETPYSYPTG
CEECCCCCCCCCCCC
24.3926356563
31PhosphorylationFLSEETPYSYPTGNH
ECCCCCCCCCCCCCC
28.4015572663
32PhosphorylationLSEETPYSYPTGNHT
CCCCCCCCCCCCCCE
26.3226356563
33PhosphorylationSEETPYSYPTGNHTY
CCCCCCCCCCCCCEE
10.0426356563
35PhosphorylationETPYSYPTGNHTYQE
CCCCCCCCCCCEEEE
42.2426356563
39PhosphorylationSYPTGNHTYQEIAVP
CCCCCCCEEEEEECC
30.7926356563
40PhosphorylationYPTGNHTYQEIAVPP
CCCCCCEEEEEECCC
9.1526356563
74O-linked_GlycosylationDQWQPSSSRFIHQQP
HHCCCCCCCCCCCCC
35.2330059200
83O-linked_GlycosylationFIHQQPQSSSPVYGS
CCCCCCCCCCCCCCC
39.1930059200
83PhosphorylationFIHQQPQSSSPVYGS
CCCCCCCCCCCCCCC
39.1922167270
84PhosphorylationIHQQPQSSSPVYGSS
CCCCCCCCCCCCCCC
33.1522167270
85O-linked_GlycosylationHQQPQSSSPVYGSSA
CCCCCCCCCCCCCCC
24.5130059200
85PhosphorylationHQQPQSSSPVYGSSA
CCCCCCCCCCCCCCC
24.5122167270
87PhosphorylationQPQSSSPVYGSSAKT
CCCCCCCCCCCCCCC
10.2517016520
88PhosphorylationPQSSSPVYGSSAKTS
CCCCCCCCCCCCCCC
18.0625159151
90O-linked_GlycosylationSSSPVYGSSAKTSSV
CCCCCCCCCCCCCCC
14.9430059200
90PhosphorylationSSSPVYGSSAKTSSV
CCCCCCCCCCCCCCC
14.9421945579
91PhosphorylationSSPVYGSSAKTSSVS
CCCCCCCCCCCCCCC
29.4421945579
94PhosphorylationVYGSSAKTSSVSNPQ
CCCCCCCCCCCCCCC
26.4223927012
95PhosphorylationYGSSAKTSSVSNPQD
CCCCCCCCCCCCCCC
28.2123927012
96PhosphorylationGSSAKTSSVSNPQDS
CCCCCCCCCCCCCCC
34.4923927012
98PhosphorylationSAKTSSVSNPQDSVG
CCCCCCCCCCCCCCC
44.7530266825
103PhosphorylationSVSNPQDSVGSPCSR
CCCCCCCCCCCCCCC
24.1130266825
106PhosphorylationNPQDSVGSPCSRVGE
CCCCCCCCCCCCCCC
22.1519664994
108S-nitrosylationQDSVGSPCSRVGEEE
CCCCCCCCCCCCCCC
4.3122126794
109PhosphorylationDSVGSPCSRVGEEEH
CCCCCCCCCCCCCCC
33.1330266825
117PhosphorylationRVGEEEHVYSFPNKQ
CCCCCCCEEECCCCC
4.9117016520
118PhosphorylationVGEEEHVYSFPNKQK
CCCCCCEEECCCCCC
13.4029255136
119PhosphorylationGEEEHVYSFPNKQKS
CCCCCEEECCCCCCC
32.8929255136
123UbiquitinationHVYSFPNKQKSAEPS
CEEECCCCCCCCCCC
60.38-
125UbiquitinationYSFPNKQKSAEPSPT
EECCCCCCCCCCCCC
53.92-
125 (in isoform 4)Phosphorylation-53.9225311616
126PhosphorylationSFPNKQKSAEPSPTV
ECCCCCCCCCCCCCE
35.0629255136
128 (in isoform 4)Phosphorylation-54.0924719451
130PhosphorylationKQKSAEPSPTVMSTS
CCCCCCCCCCEEECC
25.3829255136
132PhosphorylationKSAEPSPTVMSTSLG
CCCCCCCCEEECCCC
32.9330266825
134SulfoxidationAEPSPTVMSTSLGSN
CCCCCCEEECCCCCC
3.8830846556
135PhosphorylationEPSPTVMSTSLGSNL
CCCCCEEECCCCCCH
15.5430266825
136PhosphorylationPSPTVMSTSLGSNLS
CCCCEEECCCCCCHH
15.1829255136
137PhosphorylationSPTVMSTSLGSNLSE
CCCEEECCCCCCHHH
24.3519664994
139 (in isoform 4)Phosphorylation-17.7929507054
140PhosphorylationVMSTSLGSNLSELDR
EEECCCCCCHHHHHH
39.6330278072
141 (in isoform 4)Phosphorylation-45.8724275569
143PhosphorylationTSLGSNLSELDRLLL
CCCCCCHHHHHHHHH
40.1223927012
151 (in isoform 4)Phosphorylation-39.6918691976
154 (in isoform 4)Phosphorylation-18.2525159151
155 (in isoform 4)Phosphorylation-6.0629743597
169PhosphorylationFPADEANSSPPLPGA
CCCCCCCCCCCCCCC
51.8026356563
170PhosphorylationPADEANSSPPLPGAL
CCCCCCCCCCCCCCC
30.2830278072
178PhosphorylationPPLPGALSPLYGVPE
CCCCCCCCCCCCCCC
16.6030278072
181PhosphorylationPGALSPLYGVPETNS
CCCCCCCCCCCCCCC
21.3327259358
186PhosphorylationPLYGVPETNSPLGGK
CCCCCCCCCCCCCCC
34.6226356563
188PhosphorylationYGVPETNSPLGGKAG
CCCCCCCCCCCCCCC
28.9926356563
216PhosphorylationGLEDVRPSVESLLDE
CHHHHCHHHHHHHHH
28.1429496963
219PhosphorylationDVRPSVESLLDELES
HHCHHHHHHHHHHHH
31.8822199227
226PhosphorylationSLLDELESSVPSPVP
HHHHHHHHCCCCCCC
49.6229523821
227PhosphorylationLLDELESSVPSPVPA
HHHHHHHCCCCCCCE
28.7729523821
230PhosphorylationELESSVPSPVPAITV
HHHHCCCCCCCEEEE
36.0528192239
236PhosphorylationPSPVPAITVNQGEMS
CCCCCEEEECCCCCC
18.6023663014
243PhosphorylationTVNQGEMSSPQRVTS
EECCCCCCCCCCCCC
34.2725159151
244PhosphorylationVNQGEMSSPQRVTST
ECCCCCCCCCCCCCH
24.6025159151
249PhosphorylationMSSPQRVTSTQQQTR
CCCCCCCCCHHHHHH
28.3923403867
250PhosphorylationSSPQRVTSTQQQTRI
CCCCCCCCHHHHHHH
22.7427273156
251PhosphorylationSPQRVTSTQQQTRIS
CCCCCCCHHHHHHHC
22.4923403867
255PhosphorylationVTSTQQQTRISASSA
CCCHHHHHHHCCHHH
26.1523403867
258PhosphorylationTQQQTRISASSATRE
HHHHHHHCCHHHHHH
20.8630266825
258 (in isoform 2)Phosphorylation-20.8625311616
260PhosphorylationQQTRISASSATRELD
HHHHHCCHHHHHHHH
17.4530266825
261PhosphorylationQTRISASSATRELDE
HHHHCCHHHHHHHHH
33.1227273156
261 (in isoform 2)Phosphorylation-33.1224719451
263PhosphorylationRISASSATRELDELM
HHCCHHHHHHHHHHH
26.9922167270
270SulfoxidationTRELDELMASLSDFK
HHHHHHHHHHHCCCE
1.9330846556
272PhosphorylationELDELMASLSDFKIQ
HHHHHHHHHCCCEEC
17.9123911959
272 (in isoform 2)Phosphorylation-17.9129507054
274PhosphorylationDELMASLSDFKIQGL
HHHHHHHCCCEECCC
38.2123403867
274 (in isoform 2)Phosphorylation-38.2124275569
277UbiquitinationMASLSDFKIQGLEQR
HHHHCCCEECCCHHH
38.8321906983
284 (in isoform 2)Phosphorylation-25.8518691976
287 (in isoform 2)Phosphorylation-24.2225159151
288 (in isoform 2)Phosphorylation-45.2529743597
302PhosphorylationWPRDGGRSSPGGQDE
CCCCCCCCCCCCCCC
44.1322167270
303PhosphorylationPRDGGRSSPGGQDEG
CCCCCCCCCCCCCCC
26.6322167270
311 (in isoform 3)Phosphorylation-13.7024114839
313 (in isoform 3)Phosphorylation-2.8524114839
316 (in isoform 3)Phosphorylation-21.6921815630
318PhosphorylationGFMAQGKTGSSSPPG
CCCCCCCCCCCCCCC
49.4722167270
320PhosphorylationMAQGKTGSSSPPGGP
CCCCCCCCCCCCCCC
32.6422167270
321PhosphorylationAQGKTGSSSPPGGPP
CCCCCCCCCCCCCCC
48.4822167270
322PhosphorylationQGKTGSSSPPGGPPK
CCCCCCCCCCCCCCC
36.4922167270
332PhosphorylationGGPPKPGSQLDSMLG
CCCCCCCHHHHHHHH
35.7823927012
332 (in isoform 3)Phosphorylation-35.7825849741
334 (in isoform 3)Phosphorylation-5.8827762562
335 (in isoform 3)Phosphorylation-25.1025849741
336PhosphorylationKPGSQLDSMLGSLQS
CCCHHHHHHHHHHHH
25.2130266825
336 (in isoform 3)Phosphorylation-25.2125849741
340PhosphorylationQLDSMLGSLQSDLNK
HHHHHHHHHHHHHHH
21.1930266825
343PhosphorylationSMLGSLQSDLNKLGV
HHHHHHHHHHHHHCH
49.7323927012
352PhosphorylationLNKLGVATVAKGVCG
HHHHCHHHHHCCCCC
20.7028857561
355AcetylationLGVATVAKGVCGACK
HCHHHHHCCCCCCCC
47.7625953088
355UbiquitinationLGVATVAKGVCGACK
HCHHHHHCCCCCCCC
47.76-
371PhosphorylationPIAGQVVTAMGKTWH
CCCCCEEECCCCCCC
16.4521406692
404PhosphorylationFERDGQPYCEKDYHN
CCCCCCCCCCCCCHH
12.8328152594
409PhosphorylationQPYCEKDYHNLFSPR
CCCCCCCCHHCCCCC
12.0428152594
414PhosphorylationKDYHNLFSPRCYYCN
CCCHHCCCCCEEEEC
18.0125159151
468PhosphorylationKAYCRKDYFDMFAPK
CEEECHHHHHHCCCC
12.4320562096
471SulfoxidationCRKDYFDMFAPKCGG
ECHHHHHHCCCCCCH
1.9030846556
533PhosphorylationHYHERRGSLCSGCQK
EEECCCCCCCCCCCC
25.1323927012
536PhosphorylationERRGSLCSGCQKPIT
CCCCCCCCCCCCCCC
48.1523927012
540AcetylationSLCSGCQKPITGRCI
CCCCCCCCCCCHHHH
42.3326210075
540UbiquitinationSLCSGCQKPITGRCI
CCCCCCCCCCCHHHH
42.33-
543PhosphorylationSGCQKPITGRCITAM
CCCCCCCCHHHHHHH
27.40-
553AcetylationCITAMAKKFHPEHFV
HHHHHHHHHCHHHHH
39.0926051181
554 (in isoform 3)Ubiquitination-13.16-
570MalonylationFCLKQLNKGTFKEQN
HHHHHHCCCCCCCCC
68.8426320211
574AcetylationQLNKGTFKEQNDKPY
HHCCCCCCCCCCCCC
59.2226051181

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
31YPhosphorylationKinaseABL1P00519
GPS
31YPhosphorylationKinaseEPHB1P54762
GPS
31YPhosphorylationKinasePTK2Q05397
GPS
31YPhosphorylationKinasePTK6Q13882
GPS
31YPhosphorylationKinasePTK6Q13882
Uniprot
40YPhosphorylationKinaseSRC64-PhosphoELM
40YPhosphorylationKinaseSRCP12931
GPS
83SPhosphorylationKinaseMAPK1P28482
GPS
83SPhosphorylationKinaseMAPK3P27361
GPS
85SPhosphorylationKinaseCDK5Q00535
PSP
85SPhosphorylationKinaseMAPK14Q16539
GPS
88YPhosphorylationKinaseSRC64-PhosphoELM
88YPhosphorylationKinaseSRCP12931
PSP
118YPhosphorylationKinaseFYNP06241
PSP
118YPhosphorylationKinaseABL1P00519
GPS
118YPhosphorylationKinaseEPHB1P54762
GPS
118YPhosphorylationKinasePTK6Q13882
GPS
118YPhosphorylationKinasePTK2Q05397
GPS
118YPhosphorylationKinasePTK6Q13882
Uniprot
126SPhosphorylationKinaseMAPK3P27361
GPS
126SPhosphorylationKinaseGSK-FAMILY-GPS
126SPhosphorylationKinaseMAPK1P28482
GPS
130SPhosphorylationKinaseMAPK3P27361
GPS
130SPhosphorylationKinaseMAPK1P28482
GPS
178SPhosphorylationKinaseMAPK8P45983
GPS
244SPhosphorylationKinaseCDK5Q00535
PSP
244SPhosphorylationKinaseCDK5Q00535
Uniprot
250SPhosphorylationKinaseSLKQ9H2G2
Uniprot
258SPhosphorylationKinasePAK1Q13153
PSP
272SPhosphorylationKinasePAK1Q13153
PSP
272SPhosphorylationKinasePAK2Q13177
PSP
272SPhosphorylationKinasePAK4O96013
PSP
274SPhosphorylationKinasePAK2Q13177
PSP
-KUbiquitinationE3 ubiquitin ligaseRNF5Q99942
PMID:12861019

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
244SPhosphorylation

18042622
250SPhosphorylation

23128389

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PAXI_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FAK1_HUMANPTK2physical
11514617
FAK2_HUMANPTK2Bphysical
9099734
FAK2_HUMANPTK2Bphysical
9422762
PTN12_HUMANPTPN12physical
10400685
ITA4_HUMANITGA4physical
11533025
LCK_HUMANLCKphysical
9488700
VINC_HUMANVCLphysical
10330411
FAK1_HUMANPTK2physical
10330411
NCK1_HUMANNCK1physical
10330411
PABP1_HUMANPABPC1physical
11704675
ITA4_HUMANITGA4physical
11919182
VINC_HUMANVCLphysical
9054445
FAK1_HUMANPTK2physical
9054445
TLN1_HUMANTLN1physical
9054445
VINC_HUMANVCLphysical
8922390
FAK1_HUMANPTK2physical
8922390
ILK_HUMANILKphysical
11304546
ITB3_HUMANITGB3physical
11683411
FAK1_HUMANPTK2physical
9756887
CASL_HUMANNEDD9physical
10455189
FAK1_HUMANPTK2physical
10455189
TLN1_HUMANTLN1physical
7534286
BCR_HUMANBCRphysical
7534286
TBG1_HUMANTUBG1physical
11950600
FYN_HUMANFYNphysical
10804218
ITB1_HUMANITGB1physical
10804218
ASAP1_HUMANASAP1physical
12149250
REPS2_MOUSEReps2physical
12149250
TLN1_HUMANTLN1physical
8641358
RNF5_CAEELrnf-5physical
12861019
RNF5_HUMANRNF5physical
12861019
NAA10_HUMANNAA10physical
22863883
SC24D_HUMANSEC24Dphysical
22863883
ADA17_HUMANADAM17physical
23317503
ADA10_HUMANADAM10physical
23317503
HDAC6_HUMANHDAC6physical
25070956
TRI15_HUMANTRIM15physical
25015296
CAP1_HUMANCAP1physical
26344197
SRC8_HUMANCTTNphysical
25241761
P85A_HUMANPIK3R1physical
25241761
MK01_HUMANMAPK1physical
25241761

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PAXI_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-106, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85 AND SER-126, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83; SER-85 AND THR-318,AND MASS SPECTROMETRY.
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-106, AND MASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85; SER-106; SER-126;SER-130 AND SER-137, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-85, AND MASSSPECTROMETRY.
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis.";
Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III;
J. Proteome Res. 7:1346-1351(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND MASSSPECTROMETRY.
"Multiple reaction monitoring for robust quantitative proteomicanalysis of cellular signaling networks.";
Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84; TYR-88 AND TYR-118,AND MASS SPECTROMETRY.
"Cdk5 regulates differentiation of oligodendrocyte precursor cellsthrough the direct phosphorylation of paxillin.";
Miyamoto Y., Yamauchi J., Chan J.R., Okada A., Tomooka Y.,Hisanaga S., Tanoue A.;
J. Cell Sci. 120:4355-4366(2007).
Cited for: PHOSPHORYLATION AT SER-244.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118 AND SER-303, ANDMASS SPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-31; TYR-88 AND TYR-118,AND MASS SPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-88 AND TYR-118, AND MASSSPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118, AND MASSSPECTROMETRY.
"Time-resolved mass spectrometry of tyrosine phosphorylation sites inthe epidermal growth factor receptor signaling network reveals dynamicmodules.";
Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,Lauffenburger D.A., White F.M.;
Mol. Cell. Proteomics 4:1240-1250(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-118, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of HeLa cells using stable isotope labelingwith amino acids in cell culture (SILAC).";
Amanchy R., Kalume D.E., Iwahori A., Zhong J., Pandey A.;
J. Proteome Res. 4:1661-1671(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-88 AND TYR-118, AND MASSSPECTROMETRY.
"Brk activates rac1 and promotes cell migration and invasion byphosphorylating paxillin.";
Chen H.Y., Shen C.H., Tsai Y.T., Lin F.C., Huang Y.P., Chen R.H.;
Mol. Cell. Biol. 24:10558-10572(2004).
Cited for: PHOSPHORYLATION AT TYR-31 AND TYR-118, AND INTERACTION WITH PTK6.
"Involvement of phosphorylation of Tyr-31 and Tyr-118 of paxillin inMM1 cancer cell migration.";
Iwasaki T., Nakata A., Mukai M., Shinkai K., Yano H., Sabe H.,Schaefer E., Tatsuta M., Tsujimura T., Terada N., Kakishita E.,Akedo H.;
Int. J. Cancer 97:330-335(2002).
Cited for: PHOSPHORYLATION AT TYR-31; TYR-118 AND TYR-181.

TOP